Company
Aer Therapeutics
Targeting Mucus Obstruction to Improve Lung Health
Also known as Aer Therapeutics, Inc.
- Business model
- B2B
- Headquarters
- Research Triangle Park, NC, United States
- Legal name
- Aer Therapeutics, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Aer Therapeutics is a clinical-stage biopharmaceutical company developing first-in-class inhaled therapies that target mucus obstruction in chronic lung diseases.
Funding snapshot
- Total raised
- $20.9MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $3M2026-08-07
Funding rounds
- Round, 2026
- $3M2026-08-07, SEC form D sold, 7 investors
- Round, 2025
- $5M2025-01-24, SEC form D sold, 15 investors
- Round, 2022
- $15.9M2022-12-09, SEC form D sold, 23 investors
Products
- Web
- AER-01
Loading relationship preview